Figure 6.
Combination treatment of atRA and CVC improved liver test levels in Mdr2−/− mice. (A) plasma ALT; (B) plasma ALP; (C) plasma bilirubin; (D) plasma bile acids; (E) liver bile acid; and (F) gallbladder bile acid. * p<0.05, n=9-11.
Combination treatment of atRA and CVC improved liver test levels in Mdr2−/− mice. (A) plasma ALT; (B) plasma ALP; (C) plasma bilirubin; (D) plasma bile acids; (E) liver bile acid; and (F) gallbladder bile acid. * p<0.05, n=9-11.